BIOCON:NSE
Biocon Ltd
348,50 ₹
arrow_downward
-0,43%(-1,50) 1D
9. okt., 15.30.00 GMT+5.30 · INR
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for BIOCON...
Ã…bn
349,55 ₹
Høj
351,00 ₹
Lav
343,95 ₹
Markedsværdi
569,11Â mia.
Gns. vol.
3,09Â mio.
Volumen
1,89Â mio.
Udbytte
0,14Â %
Kvartalsvis udbytte
0,12 ₹
Ex-dato
3. jul. 2026
P/E-forhold
103,17
Højeste i 52 uger
447,15 ₹
Laveste i 52 uger
337,70 ₹
Indtægt pr. aktie
3,38 ₹
Aktier i omløb
600,00Â mio.
Antal ansatte
16Â t
Ã…bn
349,55 ₹
Høj
351,00 ₹
Lav
343,95 ₹
Markedsværdi
569,11Â mia.
Gns. vol.
3,09Â mio.
Volumen
1,89Â mio.
Udbytte
0,14Â %
Kvartalsvis udbytte
0,12 ₹
Ex-dato
3. jul. 2026
P/E-forhold
103,17
Højeste i 52 uger
447,15 ₹
Laveste i 52 uger
337,70 ₹
Indtægt pr. aktie
3,38 ₹
Aktier i omløb
600,00Â mio.
Antal ansatte
16Â t
Nyhedshistorier
Fra webkilder og nyhedspartnere
Invezz
·
for 2 dage siden
AI-boblen kan sprænge i 2027 og sende S&P 500 ned til 5.000, advarer strateg
Yahoo Finance
·
for 1 time siden
The Nasdaq-100 Has Gained 20% or More 3 Years Running. This Streak Rests on Far Stronger Earnings Than 1999's.
Seeking Alpha
·
for 5 timer siden
The 1-Minute Market Report October 10, 2026 (NYSEARCA:VOO)
Investor's Business Daily
·
for 3 timer siden
Futures: 6 Stocks Near Buy Points; Big Earnings, Inflation Data Due
Profil
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Om Biocon Ltd
Administrerende direktørShreehas P Tambe
Ansatte16,4Â t
Grundlagt29. nov. 1978
HovedsædeBangalore, Karnataka, Indien
Sektor-
Websitebiocon.com